Loading…
Loading…
your thoughts on the addressable market for that product line and client overlap with current plans?
are you seeing potential opportunities there that maybe more intriguing in the near term versus buybacks?
are you seeing noticeable improved efficiencies allowing you to convert the customers at a faster clip?
It seems to be another pretty good jump in the, you know, in R&D spend. Any more color you can shed on that?
shed some light on the abnormally high stock comp implied in the guidance.